Feedback / Questions
BGE-102 - BioAge Labs
https://www.globenewswire.com/news-release/2026/04/21/3277765/0/en/bioage-reports-positive-phase-1-data-for-bge-102-a-novel-oral-nlrp3-inhibitor-demonstrating-potential-best-in-class-reductions-in-hscrp.html
Apr 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next